Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Cree, Bruce A C Cutter, Gary Wolinsky, Jerry S Freedman, Mark S Comi, Giancarlo Giovannoni, Gavin Hartung, Hans-Peter Arnold, Douglas Kuhle, Jens Block, Valerie Munschauer, Frederick E Sedel, Frédéric Lublin, Fred D